8 results
8-K
EX-99.1
SDGR
Schrödinger, Inc.
1 Nov 23
Schrödinger Reports Third Quarter 2023 Financial Results
4:00pm
2023 Revenue Guidance
Continued Progress for SGR-1505, Healthy Volunteer Data Expected in Fourth Quarter of 2023
Phase 1 Study Initiated for SGR-2921
8-K/A
EX-99.1
SDGR
Schrödinger, Inc.
3 Aug 23
Schrödinger Reports Second Quarter 2023 Financial Results
5:10pm
preliminary data from the healthy volunteer study later this year. In addition to these two clinical-stage programs, we continue to advance our … 1 dose-escalation study in healthy volunteers. Emerging data from the healthy volunteer study support further development, and the company expects
8-K
EX-99.1
b3hutgx 9v
2 Aug 23
Schrödinger Reports Second Quarter 2023 Financial Results
4:01pm
- Prev
- 1
- Next